Kits (1)
Launched (1)
Human (1)
- (1)
- (1)
| Cat. No. | Species | Host | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|---|
RES-A098 | - | resDetect™ BSA ELISA Kit (USP Calibrated) |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| ALXN-1850 | ALXN-1850 | Phase 3 Clinical | Alexion Pharmaceuticals Inc | Hypophosphatasia | Details |
| English Name | Research Code | Highest Development Stage | Company | Earliest Brand Name | Earliest Approval Country | Earliest Indication | Earliest Approval Company | Earliest Approval Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Amifostine | NSC-296961; YM-08310; S-8744; SAPEP; WR-2721; WR-2721C | Approved | Medimmune Llc | 天地达, 安福定, Ethyol | United States | Head and Neck Neoplasms; Ovarian Neoplasms | Clinigen Inc | 1995-12-08 | Cytoprotective adjuvant; Myelodysplastic-Myeloproliferative Diseases; Salivary Gland Diseases; Mucositis; Lymphoma; Lymphoma, Non-Hodgkin; Lung Neoplasms; Bone Marrow Diseases; Sarcoma; Acute Radiation Syndrome; Breast Neoplasms; Prostatic Neoplasms; Gestational Trophoblastic Disease; Radiation Injuries; Head and Neck Neoplasms; Nasopharyngeal Neoplasms; Fanconi Anemia; Hodgkin Disease; Small Cell Lung Carcinoma; Myelodysplastic Syndromes; Neutropenia; Carcinoma; Peripheral Nervous System Diseases; Trigeminal Neuralgia; Solid tumours; Ovarian Neoplasms; Drug-Related Side Effects and Adverse Reactions | Details |

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)
メールアドレス
order.jp@acrobiosystems.com
アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8



